STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Artivion (NYSE: AORT) has announced its participation in two upcoming investor conferences in New York. The company will present at the Stifel 2024 Healthcare Conference on November 19, 2024, at 1:15p.m. ET at the Lotte New York Palace, with a live webcast available on their website. The webcast recording will be accessible for 90 days afterward.

Additionally, the management team will conduct one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024. No webcast will be available for this event due to its format.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

ATLANTA, Nov. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at the Lotte New York Palace. The Company's presentation is scheduled to begin at 1:15p.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 21, 2024, in New York. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:

 


Artivion

Gilmartin Group LLC

Lance A. Berry

Brian Johnston / Laine Morgan

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

investors@artivion.com

Phone: 770-419-3355


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302296852.html

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Stifel 2024 Healthcare Conference?

Artivion will present at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, at 1:15p.m. ET at the Lotte New York Palace.

How long will Artivion's (AORT) Stifel Conference webcast be available?

The webcast recording will be available for 90 days on Artivion's website (www.artivion.com) in the Investors section.

Will there be a webcast for Artivion's (AORT) participation in the Canaccord Genuity Forum?

No, there will not be a webcast available for the Canaccord Genuity Forum due to the one-on-one meeting format of the event.

What investor events is Artivion (AORT) attending in November 2024?

Artivion is attending the Stifel 2024 Healthcare Conference on November 19 and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.15B
43.28M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW